Sequencing of immunotherapy and targeted therapy for BRAF^V600 mutated melanoma: a retrospective study

J Dtsch Dermatol Ges. 2021 Jun;19(6):902-904. doi: 10.1111/ddg.14329. Epub 2021 Feb 22.

Authors

Oana-Diana Persa^{1

2}, Julia Elisabeth Fromme^{1

2

3}, Cornelia Mauch^{1

2}

Affiliations

¹ Department of Dermatology and Venereology, Cologne University Hospital, Germany.
² Center for Integrated Oncology, CIO ABCD, Aachen, Bonn, Cologne, Düsseldorf, Germany.
³ Mildred-Scheel-School-of-Oncology, Köln-Bonn, Germany.

PMID: 33617147
DOI: 10.1111/ddg.14329

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunotherapy
Melanoma* / drug therapy
Melanoma* / therapy
Molecular Targeted Therapy
Mutation / genetics
Protein Kinase Inhibitors / therapeutic use
Proto-Oncogene Proteins B-raf / genetics
Retrospective Studies
Skin Neoplasms* / drug therapy
Skin Neoplasms* / therapy

Substances

Protein Kinase Inhibitors
BRAF protein, human
Proto-Oncogene Proteins B-raf